Idiopathic pulmonary fibrosis primary prevention: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(4 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Idiopathic pulmonary fibrosis}}
{{Idiopathic pulmonary fibrosis}}
{{CMG}}
{{CMG}}; {{AE}} {{AEL}}  


==Overview==
==Overview==
The primary prevention of idiopathic pulmonary fibrosis or usual interstitial pneumonia includes [[smoking cessation]] and [[vaccination]] against [[influenza]].
==Primary Prevention==
==Primary Prevention==
===General Considerations===
===General Considerations===
*There are several ways to prevent pulmonary fibrosis or usual interstitial pneumonia. Appropriately treating underlying illnesses (such as [[AIDS]]) can decrease a person's risk of pneumonia.
*There are several ways to prevent pulmonary fibrosis or usual interstitial pneumonia. Appropriately treating underlying illnesses (such as [[AIDS]]) can decrease an individual's risk of [[pneumonia]].
*[[Smoking cessation]] is important not only because it helps to limit lung damage, but also because cigarette smoke interferes with many of the body's natural defenses against pneumonia.
*[[Smoking cessation]] is important not only because it helps to limit lung damage, but also because cigarette smoke interferes with many of the body's natural defenses against [[pneumonia]].
*[[Research]] shows that there are several ways to prevent pneumonia in newborn [[infant]]s. Testing pregnant women for [[Group B Streptococcus]] and ''[[chlamydia trachomatis]]'', and then giving [[antibiotic]] treatment if needed, reduces pneumonia in infants. Suctioning the mouth and throat of infants with [[meconium]]-stained [[amniotic fluid]] decreases the rate of [[aspiration pneumonia]].
*There are several ways to prevent [[pneumonia]] in newborn [[infant]]s. Testing pregnant women for [[Group B Streptococcus|Group B ''Streptococcus'']] and ''[[chlamydia trachomatis]]'', and then giving [[antibiotic]] treatment if needed, reduces [[pneumonia]] in infants. Suctioning the mouth and throat of infants with [[meconium]]-stained [[amniotic fluid]] decreases the rate of [[aspiration pneumonia]].
*[[Vaccination]] is important for preventing pneumonia in both children and adults. Vaccinations against ''[[haemophilus influenzae]]'' and ''[[streptococcus pneumoniae]]'' in the first year of life have greatly reduced their role in pneumonia in children.
*[[Vaccination]] is important for preventing [[pneumonia]] in both children and adults. Vaccinations against ''[[haemophilus influenzae]]'' and ''[[streptococcus pneumoniae]]'' in the first year of life have greatly reduced their role in [[pneumonia]] in children.
*Vaccinating children against ''streptococcus pneumoniae'' has also led to a decreased incidence of these infections in adults because many adults acquire infections from children. A [[Pneumococcal polysaccharide vaccine|vaccine against ''streptococcus pneumoniae'']] is also available for adults. <ref name="butler">Butler JC, Breiman RF, Campbell JF, Lipman HB, Broome CV, Facklam RR. Pneumococcal polysaccharide vaccine efficacy: an evaluation of current recommendations.'' JAMA'' 1993;270:1826–1831. PMID 8411526</ref>. [[Influenza]] vaccines should be given yearly to the same individuals who receive vaccination against ''[[streptococcus pneumoniae]]''. In addition, health care workers, nursing home residents, and pregnant women should receive the vaccine.<ref name="CDC">Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP)''. MMWR'' 1999;48(RR-4):1–28. PMID 10366138.</ref>
*Vaccinating children against ''[[streptococcus pneumoniae]]'' has also led to a decreased incidence of these infections in adults because many adults acquire infections from children. A [[Pneumococcal polysaccharide vaccine|vaccine against ''streptococcus pneumoniae'']] is also available for adults.<ref name="butler">Butler JC, Breiman RF, Campbell JF, Lipman HB, Broome CV, Facklam RR. Pneumococcal polysaccharide vaccine efficacy: an evaluation of current recommendations.'' JAMA'' 1993;270:1826–1831. PMID 8411526</ref>.
*When an influenza outbreak is occurring, medications such as [[amantadine]], [[rimantadine]], [[zanamivir]], and [[oseltamivir]] can help prevent influenza.<ref name="jefferson">Jefferson T, Deeks JJ, Demicheli V, Rivetti D, Rudin M. Amantadine and rimantadine for preventing and treating influenza A in adults.''Cochrane Database Syst Rev.'' 2004;(3):CD001169. PMID 15266442</ref><sup>,</sup><ref name="hayden">Hayden FG, Atmar RL, Schilling M, Johnson C, Poretz D, Paar D, Huson L, Ward P, Mills RG. Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza.'' N Engl J Med'' 1999;341:1336–1343PMID 10536125</ref>
*[[Influenza]] vaccines should be given yearly to the same individuals who receive [[vaccination]] against ''[[streptococcus pneumoniae]]''. In addition, health care workers, nursing home residents, and pregnant women should receive the [[vaccine]].<ref name="CDC">Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP)''. MMWR'' 1999;48(RR-4):1–28. PMID 10366138.</ref>
*When an [[influenza]] outbreak is occurring, medications such as [[amantadine]], [[rimantadine]], [[zanamivir]], and [[oseltamivir]] can help prevent [[influenza]].<ref name="jefferson">Jefferson T, Deeks JJ, Demicheli V, Rivetti D, Rudin M. Amantadine and rimantadine for preventing and treating influenza A in adults.''Cochrane Database Syst Rev.'' 2004;(3):CD001169. PMID 15266442</ref><sup>,</sup><ref name="hayden">Hayden FG, Atmar RL, Schilling M, Johnson C, Poretz D, Paar D, Huson L, Ward P, Mills RG. Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza.'' N Engl J Med'' 1999;341:1336–1343PMID 10536125</ref>
==References==
==References==
{{reflist|2}}
{{reflist|2}}

Latest revision as of 14:12, 3 April 2018

Idiopathic pulmonary fibrosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Idiopathic pulmonary fibrosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Idiopathic pulmonary fibrosis primary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Idiopathic pulmonary fibrosis primary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Idiopathic pulmonary fibrosis primary prevention

CDC on Idiopathic pulmonary fibrosis primary prevention

Idiopathic pulmonary fibrosis primary prevention in the news

Blogs on Idiopathic pulmonary fibrosis primary prevention

Directions to Hospitals Treating Idiopathic pulmonary fibrosis

Risk calculators and risk factors for Idiopathic pulmonary fibrosis primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]

Overview

The primary prevention of idiopathic pulmonary fibrosis or usual interstitial pneumonia includes smoking cessation and vaccination against influenza.

Primary Prevention

General Considerations

References

  1. Butler JC, Breiman RF, Campbell JF, Lipman HB, Broome CV, Facklam RR. Pneumococcal polysaccharide vaccine efficacy: an evaluation of current recommendations. JAMA 1993;270:1826–1831. PMID 8411526
  2. Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1999;48(RR-4):1–28. PMID 10366138.
  3. Jefferson T, Deeks JJ, Demicheli V, Rivetti D, Rudin M. Amantadine and rimantadine for preventing and treating influenza A in adults.Cochrane Database Syst Rev. 2004;(3):CD001169. PMID 15266442
  4. Hayden FG, Atmar RL, Schilling M, Johnson C, Poretz D, Paar D, Huson L, Ward P, Mills RG. Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza. N Engl J Med 1999;341:1336–1343PMID 10536125

Template:WH Template:WS